U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.938G>A (p.Cys313Tyr) AND Hypercholesterolemia, familial, 1

Germline classification:
Likely pathogenic (6 submissions)
Last evaluated:
Jul 11, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000211642.10

Allele description [Variation Report for NM_000527.5(LDLR):c.938G>A (p.Cys313Tyr)]

NM_000527.5(LDLR):c.938G>A (p.Cys313Tyr)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.938G>A (p.Cys313Tyr)
HGVS:
  • NC_000019.10:g.11107512G>A
  • NG_009060.1:g.23132G>A
  • NM_000527.5:c.938G>AMANE SELECT
  • NM_001195798.2:c.938G>A
  • NM_001195799.2:c.815G>A
  • NM_001195800.2:c.434G>A
  • NM_001195803.2:c.557G>A
  • NP_000518.1:p.Cys313Tyr
  • NP_000518.1:p.Cys313Tyr
  • NP_001182727.1:p.Cys313Tyr
  • NP_001182728.1:p.Cys272Tyr
  • NP_001182729.1:p.Cys145Tyr
  • NP_001182732.1:p.Cys186Tyr
  • LRG_274t1:c.938G>A
  • LRG_274:g.23132G>A
  • LRG_274p1:p.Cys313Tyr
  • NC_000019.9:g.11218188G>A
  • NM_000527.4:c.938G>A
  • P01130:p.Cys313Tyr
  • c.938G>A
Protein change:
C145Y
Links:
LDLR-LOVD, British Heart Foundation: LDLR_001871; UniProtKB: P01130#VAR_005358; dbSNP: rs875989911
NCBI 1000 Genomes Browser:
rs875989911
Molecular consequence:
  • NM_000527.5:c.938G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.938G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195799.2:c.815G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.434G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195803.2:c.557G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
8

Condition(s)

Name:
Hypercholesterolemia, familial, 1
Synonyms:
LDL RECEPTOR DISORDER; Hyperlipoproteinemia Type IIa; HYPER-LOW-DENSITY-LIPOPROTEINEMIA; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007750; MedGen: C0745103; Orphanet: 391665; OMIM: 143890

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000268591Cardiovascular Genetics Laboratory, PathWest Laboratory Medicine WA - Fiona Stanley Hospital
no assertion criteria provided
Pathogenic
(Mar 18, 2010)
germlineclinical testing

SCV000295072LDLR-LOVD, British Heart Foundation
criteria provided, single submitter

(ACGS Guidelines, 2013)
Likely pathogenic
(Mar 25, 2016)
germlineliterature only

PubMed (3)
[See all records that cite these PMIDs]

Citation Link,

SCV000606274Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, Academisch Medisch Centrum
no assertion criteria provided
Pathogenicgermlineresearch

SCV000607528Fundacion Hipercolesterolemia Familiar - SAFEHEART
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Mar 1, 2016)
germlineresearch

PubMed (1)
[See all records that cite this PMID]

SCV000840001Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Apr 25, 2018)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004822561All of Us Research Program, National Institutes of Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely Pathogenic
(Jul 11, 2023)
germlineclinical testing

PubMed (15)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes7not providednot provided6not providedclinical testing, literature only
not providedgermlineunknown1not providednot provided108544not providedclinical testing, research

Citations

PubMed

Disulfide bridges of a cysteine-rich repeat of the LDL receptor ligand-binding domain.

Bieri S, Djordjevic JT, Daly NL, Smith R, Kroon PA.

Biochemistry. 1995 Oct 10;34(40):13059-65.

PubMed [citation]
PMID:
7548065

Three-dimensional structure of a cysteine-rich repeat from the low-density lipoprotein receptor.

Daly NL, Scanlon MJ, Djordjevic JT, Kroon PA, Smith R.

Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6334-8.

PubMed [citation]
PMID:
7603991
PMCID:
PMC41512
See all PubMed Citations (15)

Details of each submission

From Cardiovascular Genetics Laboratory, PathWest Laboratory Medicine WA - Fiona Stanley Hospital, SCV000268591.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences

From LDLR-LOVD, British Heart Foundation, SCV000295072.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedliterature only PubMed (3)
2not provided1not providednot providedliterature only PubMed (3)
3not provided1not providednot providedliterature only PubMed (3)
4not provided1not providednot providedliterature only PubMed (3)
5not provided1not providednot providedliterature only PubMed (3)
6not provided1not providednot providedliterature only PubMed (3)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided
2germlineyes1not providednot provided1not providednot providednot provided
3germlineyes1not providednot provided1not providednot providednot provided
4germlineyes1not providednot provided1not providednot providednot provided
5germlineyes1not providednot provided1not providednot providednot provided
6germlineyes1not providednot provided1not providednot providednot provided

From Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, Academisch Medisch Centrum, SCV000606274.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearchnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Fundacion Hipercolesterolemia Familiar - SAFEHEART, SCV000607528.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine, SCV000840001.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This c.938G>A (p.Cys313Tyr) variant in the LDLR gene has been reported in multiple familial hypercholesterolemia patients [PMID: 9259195, 11857755, 11810272] but not observed in general population according to gnomad database. This variant has been reported by multiple clinical test center as disease-causing according to ClinVar database. Multiple in silico predictions suggest this cysteine to tyrosine is deleterious. Multiple variants causing cysteine at amino acid position 313 change to other amino acids have been reported as disease-causing in literature [PMID: 19318025, 15823288, 11257257]. Based upon above evidences, c.938G>A (p.Cys313Tyr) variant in the LDLR gene is classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From All of Us Research Program, National Institutes of Health, SCV004822561.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (15)

Description

The c.938G>A (p.Cys313Tyr) variant of the LDLR gene has been identified in heterozygous status in multiple (>10) unrelated individuals who fulfill the clinical criteria of Familial Hypercholesterolemia (FH) (PMID: 9259195, 9698020, 11040093, 11810272, 11857755, 27680772, 33269076, 23833242, 22883975, 17094996). This variant has also been identified in compound heterozygous status in two individuals with FH (PMID: 21382890). In-silico computational prediction tools suggest that the p.Cys313Tyr variant may have deleterious effect on protein function (REVEL score: 0.979). This variant affects one of the sixty highly conserved cysteine residues located within an LDLR class A or epidermal-growth-factor (EGF)-like domains of the LDLR protein. Cysteine residues in these domains have been shown to be involved in the formation of disulfide bridges, which are critical for protein structure and stability (PMID: 7548065, 7603991, 7979249). This variant is found to be absent in the general population database (gnomAD) and interpreted as likely pathogenic/pathogenic by several submitters in the ClinVar database (ClinVar ID: 226339). Other amino acid substitutions at the same codon (p.Cys313Gly, p.Cys313Trp) have been classified as likely pathogenic by several ClinVar submitters (ClinVar ID: 251538, 251540). Therefore, the c.938G>A (p.Cys313Tyr) variant in the LDLR gene is classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown108544not providednot provided1not providednot providednot provided

Last Updated: Apr 20, 2024